Researchers at Michigan State University developed the first working human heart‑like organoids that can model atrial fibrillation. Work began in 2020 under Aitor Aguirre. The three‑dimensional organoids are roughly the size of a lentil, beat rhythmically and include chamber‑like structures plus vascular networks with arteries, veins and capillaries.
The organoids are made from donated human stem cells. Colin O’Hern, a physician‑scientist student, added immune cells such as macrophages, which help developing human hearts form correctly. The team induced inflammation in the organoids and triggered an irregular heartbeat that mimics A‑fib. They then applied an anti‑inflammatory drug and saw the rhythm partially normalize.
The findings were published in Cell Stem Cell. The results suggest that long‑lived innate immune cells in organs guide heart development and rhythm, and they may help explain some congenital heart disorders. The group is collaborating with pharmaceutical and biotech partners to screen compounds for arrhythmia and heart safety.
Difficult words
- organoid — small three-dimensional structures made from cellsorganoids
- atrial fibrillation — an irregular, rapid heartbeat conditionA‑fib
- stem cell — a cell that can develop into different cell typesstem cells
- macrophage — a white blood cell that eats germs and debrismacrophages
- inflammation — the body's reaction to injury or infection
- congenital — present from birth, often a medical condition
- vascular — related to the body's blood vessels and circulation
- arrhythmia — an abnormal heart rhythm that is irregular
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How could organoids like these change the way scientists test heart medicines?
- What are the benefits and possible limits of using donated human stem cells for this research?
- How might immune cells influence heart development in babies, based on the article?
Related articles
Gene Variant Raises Heart Failure Risk After Myocarditis in Children
A study found that a cardiomyopathy gene variant is more common in children who develop dilated cardiomyopathy after myocarditis. Researchers describe a "double hit" model and advise genetic testing to identify higher risk.
Untreated Sleep Apnea Speeds Heart Aging and Raises Death Risk
A laboratory study using a long-term mouse model finds that untreated obstructive sleep apnea — recreated by repeated drops in oxygen during sleep — leads to faster cardiovascular aging and higher mortality. Researchers call for early screening and treatment.
Biodegradable patch may help heart heal after heart attack
Researchers report a biodegradable microneedle patch that delivers interleukin-4 to injured heart tissue. The local treatment encourages healing immune cells, reduces scarring, and may improve heart recovery while avoiding systemic side effects.
Cell transplant may help heart after spinal cord injury
Researchers tested transplanting immature nerve cells into spinal cord injuries in rats. The transplants improved nerve control of circulation — stabilizing resting blood pressure and lowering heart rate — but hormonal responses after injury still rose.